By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

EBOS Group Limited (EBOSY)

OTC Market Data in USD, Fundamentals in NZD
$41.94
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$2.06B
Market Cap
0.00
P/E Ratio (TTM)
2.55%
Forward Dividend Yield
$41.94 - $47.00
52 Week Range

EBOSY Stock Price Chart

Explore EBOS Group Limited interactive price chart. Choose custom timeframes to analyze EBOSY price movements and trends.

EBOSY Company Profile

Discover essential business fundamentals and corporate details for EBOS Group Limited (EBOSY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Specialties

IPO Date

11 May 2017

Employees

5.20K

CEO

John Cullity

Description

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

EBOSY Financial Timeline

Browse a chronological timeline of EBOS Group Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 17 Feb 2026

Earnings released on 27 Aug 2025

Dividend declared on 3 Mar 2025

A dividend of $0.54 per share was announced, adjusted to $0.54. The dividend was paid on 7 Apr 2025.

Earnings released on 19 Feb 2025

EPS came in at $0.75 , while revenue for the quarter reached $3.96B .

Earnings released on 23 Oct 2024

Dividend declared on 3 Sept 2024

A dividend of $0.76 per share was announced, adjusted to $0.76. The dividend was paid on 3 Oct 2024.

Earnings released on 20 Aug 2024

EPS came in at $0.93 , while revenue for the quarter reached $4.35B .

Earnings released on 7 May 2024

Earnings released on 20 Feb 2024

EPS came in at $0.93 , while revenue for the quarter reached $4.29B .

Earnings released on 30 Jun 2023

EPS came in at $0.86 , while revenue for the quarter reached $4.12B .

Dividend declared on 2 Mar 2023

A dividend of $0.69 per share was announced, adjusted to $0.69. The dividend was paid on 17 Mar 2023.

Earnings released on 31 Dec 2022

EPS came in at $0.93 , while revenue for the quarter reached $4.12B .

Dividend declared on 8 Sept 2022

A dividend of $0.62 per share was announced, adjusted to $0.62. The dividend was paid on 30 Sept 2022.

Earnings released on 30 Jun 2022

EPS came in at $0.77 , while revenue for the quarter reached $3.94B .

Dividend declared on 3 Mar 2022

A dividend of $0.67 per share was announced, adjusted to $0.67. The dividend was paid on 18 Mar 2022.

Earnings released on 31 Dec 2021

EPS came in at $0.90 , while revenue for the quarter reached $3.84B .

Dividend declared on 9 Sept 2021

A dividend of $0.68 per share was announced, adjusted to $0.68. The dividend was paid on 24 Sept 2021.

Earnings released on 30 Jun 2021

EPS came in at $0.87 , while revenue for the quarter reached $3.51B .

Dividend declared on 4 Mar 2021

A dividend of $0.64 per share was announced, adjusted to $0.64. The dividend was paid on 18 Mar 2021.

Earnings released on 31 Dec 2020

EPS came in at $0.82 , while revenue for the quarter reached $3.36B .

Dividend declared on 24 Sept 2020

A dividend of $0.55 per share was announced, adjusted to $0.55. The dividend was paid on 9 Oct 2020.

EBOSY Stock Performance

Access detailed EBOSY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run